Viewing StudyNCT03090815



Ignite Creation Date: 2024-05-06 @ 9:53 AM
Last Modification Date: 2024-10-26 @ 12:20 PM
Study NCT ID: NCT03090815
Status: UNKNOWN
Last Update Posted: 2017-03-27
First Post: 2016-03-30

Brief Title: Circulating Tumor DNA ctDNA as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma
Sponsor:
Organization: The University of Hong Kong

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: True
Target Duration: 2 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 100
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
40429
Who Masked List: